failure to respond or late response
on 24 Feb 2021
Last Applicant/ Owned by
1 Deer Park Drive, Suite E
Monmouth Junction
NJ
08852
Serial Number
88811756 filed on 26th Feb 2020
Registration Number
N/A
Filing Basis
1. use application currently
Disclaimer
"ONCOLOGY"
The mark consists of the word "ELUCIDA" with an arrow underneath extending in to the letter "O" of the word "ONCOLOGY". "ONCOLOGY" Color is not claimed as a feature of the mark. The English translation of "ELUCIDA" in the mark is "ELUCIDATE". Development of pharmaceutical preparations and medicines in the field of Oncology; Laboratory research services relating to pharmaceuticals, namely, prepRead More
Development of pharmaceutical preparations and medicines in the field of Oncology; Laboratory research services relating to pharmaceuticals, namely, preparations and diagnostic solutions in the field of Oncology; Pharmaceutical drug development services in the field of Oncology; Pharmaceutical products development in the field of Oncology; Pharmaceutical research and development in the field of Oncology
30th Nov 2015
31st Dec 2019
No 88811756
No Service Mark
No ELU-525-4
No
No
No
No
No
No
No
No
24.15.03 -
Arrows formed by words, letters, numbers or punctuation
26.17.13 -
Letters or words underlined and/or overlined by one or more strokes or lines
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
The mark consists of the word "ELUCIDA" with an arrow underneath extending in to the letter "O" of the word "ONCOLOGY".
Status Date | Action Taken |
---|---|
24th Feb 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
24th Feb 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
13th Aug 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
13th Aug 2020 | FINAL REFUSAL E-MAILED |
13th Aug 2020 | FINAL REFUSAL WRITTEN |
23rd Jul 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
22nd Jul 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
22nd Jul 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
18th May 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
18th May 2020 | NON-FINAL ACTION E-MAILED |